Two Sigma Securities’s Orphazyme A/S ORPH Stock Holding History

Two Sigma Securities’s Portfolio ORPH Stock Details ORPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-13,942	Closed	-$34K	–	2691
2021 Q4	$34K	Buy	+13,942	New	+$49.2K	﹤0.01%	1339

Other funds holding ORPH

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

Two Sigma Securities's ORPH Position: Q1 2022 in Review

Two Sigma Securities sold out of Orphazyme A/S (ORPH) in Q1 2022, closing a stake of 13,942 shares — an estimated $34K sold.

Two Sigma Securities first reported a position in ORPH in Q4 2021 and held it in 1 quarter. The position peaked at $34K in Q4 2021. 4 funds tracked by Wall St. Rank hold ORPH as of Q1 2022.

Two Sigma Securities reported no remaining Orphazyme A/S position as of Q1 2022 after selling out during the quarter.
Two Sigma Securities sold 13,942 Orphazyme A/S shares in Q1 2022, an estimated $34K.
Two Sigma Securities first reported a position in Orphazyme A/S in Q4 2021 and held it in 1 quarter.
Two Sigma Securities's Orphazyme A/S position peaked at $34K in Q4 2021.
4 funds tracked by Wall St. Rank held Orphazyme A/S as of Q1 2022.

Based on Two Sigma Securities's 13F filing for Q1 2022, filed 16 May 2022.